An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles directly for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.
Service Response and Material Elimination
According to the social media company, the platform has taken down violative material and banned related hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in enhancing compliance measures.
Digital Marketplace Operations
Research also found groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of joining one community, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Details and Costs
Within these groups, posts display dark colored packages with postal service labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially significant health risks”.
